tiprankstipranks
pc:sscnl

SSC 8N Lofts 2025 Sub REIT LLC

220 South St Suite #201 West Lafayette, IN 47906, US
https://muinzer.com/
A Delaware-formed private real estate investment vehicle structured as a sub-REIT focused on loft and residential property investments and related finance. The issuer offers pooled investment fund interests and Series A redeemable cumulative preferred units to accredited investors under Regulation D exemptions.

Leadership & Board

Current Number of Employees5
Current LinkedIn Followers93

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$63K
Total Amount Raised$63K
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$63K
Latest Funding Amount$63K
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 30, 2026
Series A
$62.50K
―

Similar Companies

A snapshot of private companies similar to SSC 8N Lofts 2025 Sub REIT LLC, helping you discover and navigate related company profiles.
PC:VELVRVelvære
PC:CAM26Cambio
PC:ISEMIIsemia
PC:APPWOAppWork

Related News and Analysis

Ractigen Reaches Key Phase II Milestone for RAG-17 in SOD1-ALS Program

Ractigen Reaches Key Phase II Milestone for RAG-17 in SOD1-ALS Program

New updates have been reported about Ractigen Therapeutics. Ractigen Therapeutics has completed patient enrollment and initial dosing in...
9m ago
RACTI
Hadrian Secures $1.37 Billion Series D to Scale AI-Driven Defense Manufacturing Network

Hadrian Secures $1.37 Billion Series D to Scale AI-Driven Defense Manufacturing Network

New updates have been reported about Hadrian. Hadrian has raised $1.37 billion in new equity financing at a...
9m ago
HADRI
Mediar Therapeutics Strikes Option-Backed Fibrosis Alliance With Ono, Advances Antibody Pipeline

Mediar Therapeutics Strikes Option-Backed Fibrosis Alliance With Ono, Advances Antibody Pipeline

New updates have been reported about Mediar Therapeutics. Mediar Therapeutics has signed a collaboration and option agreement with...
37m ago
MED72
KuCoin Pay Launches Stablecoin Gift Card Platform for Enterprise Distribution

KuCoin Pay Launches Stablecoin Gift Card Platform for Enterprise Distribution

New updates have been reported about KuCoin. KuCoin is expanding its payments infrastructure with the launch of KuCoin...
1h ago
KUCOI
Envision Energy Launches 2GW Galaxy Campus to Anchor Green AI Infrastructure Strategy

Envision Energy Launches 2GW Galaxy Campus to Anchor Green AI Infrastructure Strategy

New updates have been reported about Envision Energy. Envision Energy has commissioned its Galaxy Campus in Ulanqab, Inner...
2h ago
ENV6X
Acrab launches GΞLIX 1 edge AI SoC and Agent Box to localize 100B-parameter models

Acrab launches GΞLIX 1 edge AI SoC and Agent Box to localize 100B-parameter models

New updates have been reported about Acrab. Acrab has introduced GΞLIX 1, its first edge AI system-on-chip, and...
5h ago
ACRAB
Acrab Secures $130 Million Series B to Scale Agentic AI Compute Platform

Acrab Secures $130 Million Series B to Scale Agentic AI Compute Platform

New updates have been reported about Acrab. Acrab has raised US$130 million in a Series B round to...
5h ago
ACRAB
Shelfmark Secures $3.5 Million Seed to Scale Physical AI for Continuous-Flow Manufacturing

Shelfmark Secures $3.5 Million Seed to Scale Physical AI for Continuous-Flow Manufacturing

New updates have been reported about Shelfmark. Shelfmark has raised a $3.5 million seed round to accelerate deployment...
6h ago
SHELF
Worldscape Secures $10 Million Seed Extension to Scale AI-Driven Mission Engineering Platform

Worldscape Secures $10 Million Seed Extension to Scale AI-Driven Mission Engineering Platform

New updates have been reported about Worldscape. Worldscape has raised a $10 million seed extension to accelerate development...
6h ago
WOR3H
Insilico Advances AI-Designed Ocular Drug ISM9077 as Preclinical Candidate

Insilico Advances AI-Designed Ocular Drug ISM9077 as Preclinical Candidate

New updates have been reported about Insilico Medicine. Insilico Medicine has nominated ISM9077, an AI-designed, potential first-in-class inhibitor...
11h ago
INSIL